对《辅助同步放化疗与单纯化疗治疗可切除胆管癌的疗效比较》一文的更正
Correction to: Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer.
作者信息
Kim Hyera, Heo Mi Hwa, Kim Jin Young
机构信息
Division of Hematology and Oncology, Department of Internal Medicine, Keimyung University, Dongsan Medical Center, 56 Dalseong-ro, Jung-gu, Daegu, 41931, South Korea.
出版信息
BMC Gastroenterol. 2020 Jul 2;20(1):207. doi: 10.1186/s12876-020-01347-3.
Abstract
An amendment to this paper has been published and can be accessed via the original article.
摘要
本文的一篇修订已发表，可通过原始文章获取。
相似文献
1
Correction to: Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer.对《辅助同步放化疗与单纯化疗治疗可切除胆管癌的疗效比较》一文的更正
BMC Gastroenterol. 2020 Jul 2;20(1):207. doi: 10.1186/s12876-020-01347-3.
2
Adjuvant therapy for resected biliary tract cancer: a review.切除术后胆道癌的辅助治疗：综述
Chin Clin Oncol. 2016 Oct;5(5):64. doi: 10.21037/cco.2016.08.05. Epub 2016 Sep 5.
3
Adjuvant chemotherapy for resected biliary tract cancers: a systematic review and meta-analysis.切除术后胆道癌的辅助化疗：一项系统评价和荟萃分析。
HPB (Oxford). 2017 Sep;19(9):741-748. doi: 10.1016/j.hpb.2017.05.010. Epub 2017 Jul 3.
4
Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses.比较卡培他滨和顺铂辅助化疗与同期放化疗治疗胃癌的 III 期临床试验：胃癌辅助放化疗临床试验的最终报告，包括生存和亚组分析。
J Clin Oncol. 2015 Oct 1;33(28):3130-6. doi: 10.1200/JCO.2014.58.3930. Epub 2015 Jan 5.
5
Comparison of concurrent chemoradiotherapy followed by adjuvant chemotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a meta-analysis of 793 patients from 5 randomized controlled trials.同步放化疗后辅助化疗与单纯同步放化疗治疗局部晚期鼻咽癌的比较：对来自5项随机对照试验的793例患者的荟萃分析
Asian Pac J Cancer Prev. 2012;13(11):5747-52. doi: 10.7314/apjcp.2012.13.11.5747.
6
Randomized Phase II Trial Comparing Chemoradiotherapy with Chemotherapy for Completely Resected Unsuspected N2-Positive Non-Small Cell Lung Cancer.随机对照 II 期临床试验比较完全切除的意外 N2 阳性非小细胞肺癌的放化疗与单纯化疗。
J Thorac Oncol. 2017 Dec;12(12):1806-1813. doi: 10.1016/j.jtho.2017.09.1954. Epub 2017 Sep 28.
7
A pilot study of S-1-based concurrent chemoradiotherapy in patients with biliary tract cancer.一项关于以S-1为基础的同步放化疗用于胆管癌患者的初步研究。
Cancer Chemother Pharmacol. 2014 Oct;74(4):861-5. doi: 10.1007/s00280-014-2565-y. Epub 2014 Aug 17.
8
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial.同期放化疗加辅助化疗与单纯同期放化疗治疗局部晚期鼻咽癌患者的随机对照 3 期多中心临床试验。
Lancet Oncol. 2012 Feb;13(2):163-71. doi: 10.1016/S1470-2045(11)70320-5. Epub 2011 Dec 7.
9
A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer.一项关于D2切除的胃癌患者辅助性S-1/顺铂化疗后再进行基于S-1的同步放化疗的II期研究。
Cancer Chemother Pharmacol. 2016 Mar;77(3):605-12. doi: 10.1007/s00280-016-2973-2. Epub 2016 Feb 5.
10
[Adjuvant concurrent chemoradiotherapy for resected locally advanced lung cancer outpatients].[辅助同步放化疗用于可切除的局部晚期肺癌门诊患者]
Kyobu Geka. 2008 Jan;61(1):15-8.
本文引用的文献
1
Comparison of the effects of adjuvant concurrent chemoradiotherapy and chemotherapy for resected biliary tract cancer.比较辅助同步放化疗与化疗对可切除胆道癌的疗效。
BMC Gastroenterol. 2020 Jan 28;20(1):20. doi: 10.1186/s12876-020-1171-1.
Zotero 插件